TABLE 4

Results of blood-brain barrier penetration studies for five Y2R antagonists and BIIE0246

IDBrain Penetration Studies
Plasma ConcentrationBrain ConcentrationRatio [B]/[P]
μM%
SF-118.5 ± 3.33.7 ± 1.744
SF-211.1 ± 0.10.4 ± 0.0336
SF-221.6 ± 0.61.7 ± 0.6106
SF-319.0 ± 0.74.5 ± 0.350
SF-411.3 ± 0.31.5 ± 0.2115
BIIE024612 ± 20.2 ± 0.12